Octreoteva (Octreotide Acetate)

Octreotide Acetate, the active ingredient in Octreoteva, is a peptide somatostatin analogue presented as a sterile solution for subcutaneous injection use. It controls hormone‑related symptoms and tumor‑related secretions in adults and children. GNH USA supplies Octreoteva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Octreoteva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Octreotide Acetate is a synthetic peptide that modulates neuro‑endocrine pathways and is employed in several endocrine‑related conditions.

- Acromegaly: reduces growth hormone and IGF‑1 levels, helping control disease activity. - Neuroendocrine Tumors (NETs): alleviates symptoms of carcinoid syndrome and reduces flushing and diarrhea. - Vaso‑occlusive complications of idiopathic gastro‑intestinal bleeding (eg VIP‑S  ​  ).

The         …  ...  … ... ...  … … … ...  …